Source: Annual Congress 2010 - COPD: diagnosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Konopkina, T. Pertseva, N. Efimova, K. Gashynova, N. Klimenko (Dnopropetrovs'k, Ukraine). Smoking and exhaled NO concentration in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 4021

Member's Comments

No comment yet.

Related content which might interest you: Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 COPD: Exhaled NO concentration and its prognostic value for smoking patient Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 The effect of smoking and COPD on exhaled breath temperature Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Exhaled leukotrienes in smoking and non-smoking patients with chronic asthma Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006 Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Exhaled breath temperature in COPD patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Exhaled bimarkers in exacerbation of COPD Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007 Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled breath temperature as a possible early marker in smokers at risk for COPD (MARKO study) Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005 Exhaled breath condensate nitrate/nitrite in asthma, COPD and healthy controls Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Exhaled NO and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated smoking asthmatics Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010